Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Clinical Trial1
- Randomized Controlled Trial1
- Clinical Study1
- Comparative Study1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Arch Intern Med1
Search Results
Sort by
- BookAamir Ahmad, Shirish Gadgeel, editors.Contents:
1. Lung Cancer Statistics
2. Epidemiology of Lung Cancer
3. Lung Cancer In Never Smokers
4. Immune Therapy
5. Anti-angiogenesis in personalized therapy of lung cancer
6. Target therapy in Lung Cancer
7. Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: an update
8. KRAS-Mutant Lung Cancers in the Era of Targeted Therapy
9. Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer
10. Chemotherapy Resistance in Lung Cancer
11. Current state of metal-based drugs for the efficient therapy of lung cancers and lung metastases.Digital Access Springer 2016Access via Advances in experimental medicine and biology ; 2016; 893LocationVersionCall NumberItems - ArticleBranda RF, Amsden TW, Jacob HS.Arch Intern Med. 1977 Jan;137(1):65-9.A prospective, randomized, double-blind study was designed to determine the effectiveness and toxicity of nandrolone phenpropionate in the treatment of anemias due to bone marrow failure. Twenty-four patients were initially entered; 21 now may be evaluated: seven with aplastic anemia, six with myelofibrosis, and eight with refractory anemia. Six patients improved, but only three were taking nandrolone, the other three placebo. Response did not correlate with type of anemia. No serious drug toxicity was noted. One patient with myelofibrosis improved dramatically with placebo therapy alone, no longer requiring frequent transfusions because of a hemoglobin level increase from 5.4 to 15.8 gm/100 ml. We conclude that no substantial improvement of anemia due to marrow failure can be ascribed to nandrolone as given, and that clinical trials in these conditions should be controlled to exclude spontaneous remissions as a cause of apparent improvement.